Citations

Clear

79 citation(s) found for "Johnson, Matthew".

Inter‐software variability of Centiloid quantification in amyloid PET: A head‐to‐head comparison of five software platforms
Zhang, Jun , MD, Miller, Dizdar, Nur, Johnson, Matthew P. , Bilgin, Cem, Kemp, Bradley J. , Durski, Jolanta M. , Lowe, Val, Johnson, Derek R., Burkett, Brian J. , Schwarz, Christopher G. , Bilgin, Cem , Lowe, Val J.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | August 13, 2026 | Volume: 18 | Issue: 3 | Pages: No page available

10.1002/dad2.70443 | PMID 42597411 Get It

Abstract INTRODUCTION Centiloid (CL) scaling standardizes amyloid positron emission tomography (PET) quantification across tracers and platforms; however, variability across software implementations may affect diagnostic classification. This study evaluated inter‐software variability and diagnostic performance across five platforms using identical 1 8 F‐florbetapir datasets. METHODS Retrospectively, 192 patients undergoing 1 8 F‐florbetapir PET/computed tomography (CT) and magnetic resonance imaging (MRI) were analyzed. CL values were generated using four US Food and Drug Administration (FDA) ‐cleared platforms and an in‐house Centiloid standard pipeline. Agreement was assessed using intraclass correlation coefficient, with bias and limits of agreement evaluated by linear modeling and Bland–Altman analysis. Diagnostic performance was assessed using receiver operating characteristic (ROC) analysis and classification against visual interpretation. RESULTS Agreement was excellent (intraclass correlation coefficient [ICC] 0.969; 95%CI 0.961–0.975). Some platforms produced systematically higher CL values versus others slightly lower. LoA reached ± 30 CL. Diagnostic accuracy was high (area under the curve [AUC]: 0.949–0.975), with sensitivity 0.923–0.968 and specificity 0.667–0.806. DISCUSSION Despite excellent agreement, systematic differences persist and may affect classification near thresholds, supporting consistent use of a single processing pipeline.
Coccidioidal Peritonitis: Clinical Characteristics, Treatment and Outcomes
Shubeilat, Jamilah , Nagarakanti, Sandhya , Almajali, Abeer , Quillen, Jaxon , Buras, Matthew , Speiser, Lisa, Blair, Janis E. , Shubeilat, Jamilah , Nagarakanti, Sandhya Rani , Quillen, Jaxon K , Buras, Matthew R , Blair, Janis E , Speiser, Lisa

Mayo Clinic

Journal of Fungi | July 3, 2026 | Volume: 12 | Issue: 7 | Pages: 489

10.3390/jof12070489 | PMID 42506251 Get It

Peritoneal coccidioidomycosis is a rare, disseminated manifestation of Coccidioides infection with limited representation in the literature. We report 37 proven or probable cases from a single institution, including 12 patients (32%) with immunosuppression. Thirty-six patients received antifungal therapy, all of whom demonstrated clinical response. Among 11 (29.7%) patients who completed and stopped therapy after a median duration of 26 months, 2 (5%) experienced a relapse and were successfully retreated. Nine patients (24%) had no known relapse. Thirteen patients (35%) required modification of antifungal regimens, primarily due to azole adverse effects. Treatment approaches and median duration of therapy (57 months) were similar between immunosuppressed and non-immunosuppressed groups. No deaths were attributable to infection. Overall, outcomes were favorable, with strong clinical responses to azole therapy. Patients without identifiable immunologic deficits or additional sites of dissemination, when managed with antifungal therapy and close clinical, radiologic, and serologic monitoring, may achieve good prognosis, particularly when indefinite azole therapy is not feasible.
An APOE *4-Informed Genomic Atlas of the X Chromosome in Alzheimer’s Disease
Cook, Noah , Zeng, Youjie , Yang, Chenyu , Jiang, Zhiwen , Wang, Ting‐Chen , Guen, Yann Le , Cody, Karly Alex , Johnson, Matthew, Zhang, Rui, Merritt, Victoria C. , Hauger, Richard L. , Program, the VA Million Veteran, FinnGen, Koran, Mary Ellen, Mormino, Elizabeth C. , Gordon, Brian , DeCasien, Alex, Andrews, Shea J. , Logue, Mark, Greicius, Michael D. , Le Guen, Yann , Cody, Karly A , Koran, Mary Ellen , Gordon, Brian A , Andrews, Shea , Dumitrescu, Logan , Archer, Derek , Seto, Mabel , Pottier, Cyril , Cruchaga, Carlos , Sherva, Richard , Logue, Mark W. , Napolioni, Valerio , Belloy, Michael E , Cook, Noah , Zeng, Youjie , Yang, Chenyu , Zhang, Rui, Merritt, Victoria C. , Hauger, Richard L. , Koran, Mary Ellen I. , Mormino, Elizabeth C. , DeCasien, Alex R. , Dumitrescu, Logan , Archer, Derek B. , Hohman, Timothy J. , Belloy, Michaël E.

Mayo Clinic

No container title available | May 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.05.05.26352461 | PMID 42145643 Get It

Abstract The genetic contributions of the X chromosome to Alzheimer’s disease (AD) remain poorly understood yet are expected to importantly shape sex differences in AD. We therefore performed large-scale X-chromosome-wide association studies (N=1,240,451), evaluating differential risk due to sex, APOE *4, and escape from X-chromosome inactivation, finding most X-linked loci appear relevant to female-biased AD etiology. In evaluating genetic pleiotropy with hormonal, lipid, and brain imaging traits, we discovered X-linked AD loci converged on white matter traits, particularly in the anterior corona radiata and splenium of the corpus callosum. Through brain-centric functional genomics analyses, we then nominated candidate causal genes, including 5 that appeared highly robust. Notably, we found the escape gene RBBP7 decreases AD risk in APOE *4 carriers likely through higher expression in excitatory neurons to counter tau-related neurodegeneration. Altogether, we provide an atlas of sex and APOE *4-informed candidate X-linked AD risk loci, genes, and mechanisms that will guide future studies.
Next-generation AI for visually occult pancreatic cancer detection in a low-prevalence setting with longitudinal stability and multi-institutional generalisability
Mukherjee, Sovanlal , Antony, Ajith , Trivedi, Kamaxi H. , Karbhari, Aashna , Bhinder, Khurram Khaliq , Truty, Mark, Johnson, Matthew P. , Goenka, Ajit H. , Patnam, Nandakumar G. , Chari, Suresh T , Goenka, Ajit Harishkumar , Zarrintan, Armin , Fletcher, Joel G. , Truty, Mark J. , Chari, Suresh T.

Mayo Clinic

Gut | April 29, 2026 | Volume: No volume available | Issue: No issue available | Pages: gutjnl-2025-337266

10.1136/gutjnl-2025-337266 | PMID 42049489 Get It

Background Failure of conventional imaging to detect pancreatic ductal adenocarcinoma (PDA) at its visually occult pre-diagnostic stage is a primary barrier to improving its otherwise poor rate of survival. Objective To develop and validate the Radiomics-based Early Detection MODel (REDMOD), an AI framework to identify subvisual radiomic signatures of pre-diagnostic PDA on standard-of-care CT. Designs REDMOD was trained on a multi-institutional cohort (n=969; 156 pre-diagnostic, 813 control) and tested on an independent set (n=493; 63 pre-diagnostic, 430 control), simulating a low prevalence (~1:6) early detection paradigm. The fully automated framework couples AI-driven segmentation with a heterogeneous ensemble architecture trained on a 40-feature radiomic signature derived from Synthetic Minority Over-sampling Technique (SMOTE)-balanced data. A tunable Youden Index-optimised classification threshold enables performance calibration without retraining. Validation included direct comparison with radiologists, longitudinal test–retest analysis and external specificity validation across two independent cohorts (n=539 and n=80). Results On an independent test set (n=493), REDMOD identified occult PDA (AUC 0.82; 73.0% sensitivity) at a median 475-day lead time. This represented nearly twofold higher sensitivity than radiologists (38.9%; p<0.001), which grew to nearly threefold (68.0% vs 23.0%) at >24 months lead time. REDMOD showed strong longitudinal stability (90–92% concordance) and generalisable specificity across multi-institutional (81.3%; n=539) and public (87.5%; n=80) datasets. Mechanistic analyses confirmed predictive power derived principally from multi-scale wavelet-filtered textural features (90% of selected signature), which outperformed unfiltered features (AUC 0.82 vs 0.74; p=0.007) in capturing subvisual architectural disruptions. Conclusions REDMOD is an automated, mechanistically grounded, longitudinally stable, externally validated AI that surpasses radiologists for PDA detection at its visually occult pre-diagnostic stage. These attributes position it for prospective validation in high-risk cohorts, a necessary step towards shifting the paradigm from late-stage symptomatic diagnosis to proactive pre-clinical interception.
Health Care Use and Outcomes Among Participants Enrolled in the Mayo Clinic Primary Care House Call Program: A Case-Control Study
Takahashi, Paul Y. , Sohn, Bonnie C. , Verdoorn, Brandon P. , Chandra, Anupam , Mohammad, Natalie F, Philpot, Lindsey M. , Havyer, Rachel D. , Roellinger, Daniel , Johnson, Matthew G. , West, Jennifer, Hanson, Gregory J. , Garza, Maria D. Mendoza De la, Mendoza De la Garza, Maria D, Philpot, Lindsey M , Takahashi, Paul , Mohammad, Natalie F. , Hanson, Gregory J., Garza, Maria Mendoza de la

Mayo Clinic

Journal of Primary Care & Community Health | April 3, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.1177/21501319261432120 | PMID 41928581 Get It

Introduction/Objectives: House call programs provide care for homebound patients. We conducted a case-control study to compare hospitalization and/or emergency department (ED) use by patients enrolled in a primary care house call program versus ambulatory (community-dwelling) patients. Methods: Program enrollees (cases) were matched by age and self-reported gender to community-dwelling patients (controls). The primary exposure was the combination of hospitalization and/or ED visits for 1 year before the index date (October 1, 2024). We used unadjusted and adjusted conditional logistic regression to determine differences in health care use. Results: We identified 26 cases (median [range] age, 84 [66-98] years; 16 [62%] female) and 130 controls. All cases had 4 or more chronic diseases, as compared with 87 (67%) of controls ( P = .003). A higher proportion of cases than controls had previous hospitalization and/or ED visits (84.6% vs 27.7%; P < .001). After adjusting for the number of chronic illnesses, no differences in previous hospitalization and/or ED use were identified between groups. Conclusions: Cases had more chronic illnesses and more hospitalizations and/or ED visits than community-dwelling controls. The comorbid health burden of participants in the house call program drove greater health care use and justifies a higher level of care for this medically complex patient population.
Training for pediatric cannot intubate cannot oxygenate: surgical airway should replace needle cricothyrotomy
Lehman, Allison M.B., Amstutz, Paul, Moore, Jackson E. , Obersteadt, Christopher, Williams, Dominique, Waxman, Mary J., Blubaugh, Morgan , Parikh, Anaya, Walsh, Timothy R., Bruegger, Daniel E., Malik, Adrienne , Pirotte, Andrew, Johnson, Matthew D. , Obersteadt, Chris, Sood, Shawn , Pirotte, Andrew P.

Mayo Clinic

Frontiers in Disaster and Emergency Medicine | March 17, 2026 | Volume: 4 | Issue: No issue available | Pages: No page available

10.3389/femer.2026.1772381 | PMID 41928873 Get It

Failed pediatric endotracheal intubation, prompting surgical airway management via emergency front of neck access (eFONA), is an intrinsically challenging topic. While rare, all emergency airway providers must be equipped to handle these complex clinical scenarios, both through initial training and maintenance of competency. Needle cricothyrotomy is a commonly taught method in cannot intubate cannot oxygenate (CICO) scenarios for children under age eight. However, needle cricothyrotomy is technically difficult, profoundly rare, and maintaining competency is a challenge. From a multidisciplinary perspective, we examine the utility of continuing to teach needle cricothyrotomy and explore alternatives. This project group suggests that pediatric eFONA training across disciplines should focus on surgical tracheotomy rather than needle cricothyrotomy, with consideration given to specialty-specific human performance factors.
Reduction of Erroneous ST-segment Elevation Myocardial Infarction Diagnoses
Klassen, Aaron B. , Chesney, Julie A., Wilson, Marcia J., Eastman, Susan C., Connelly, Rebecca A., Konz, Brent A, Bartelt, Jennifer M., Ring, Michael T, Winkel, Daniel, Churchill, Jason T, Griffin, Dawn M., Brady, Brian J., Bartelt, J., Johnson, Matthew P. , Gulati, Rajiv , Bennett, Courtney , Barsness, Gregory W. , Bartelt, Jason D, Wiley, Brandon, Porter, John L. , Chesney, Julie A., Wilson, Marcia J., Eastman, Susan C., Fatema, Kaniz , Connelly, Rebecca A., Winkel, Daniel B., Griffin, Dawn M., Brady, Brian J., Bartelt, Jason D., Wiley, Brandon M.

Mayo Clinic

CIN: Computers, Informatics, Nursing | December 17, 2025 | Volume: 44 | Issue: 2 | Pages: No page available

10.1097/cin.0000000000001379 | PMID 41371987 Get It

An ST-segment elevation myocardial infarction is a life-threatening condition within the spectrum of acute coronary syndrome, with well-recognized implications for short-term and long-term health outcomes. Retrospective review of our institutional electronic health records identified patterns of inaccurate acute coronary syndrome diagnostic assignment, including the presence of erroneous ST-segment elevation myocardial infarction diagnoses in discharge records. Such erroneous diagnoses in the durable health record may increase risk to patients through inadequate risk assessment and inappropriate follow-up care. Misapplication of a shortcut in our electronic health record system for rapidly ordering emergent cases was identified as a potential cause of the quality gap. To address this issue, a nurse-led quality improvement project was developed by using the define, measure, analyze, improve, and control framework. The project intervention decreased the percentage of patients with erroneous diagnoses from 24% to 7% and marginally improved nursing staff satisfaction. Our project successfully addressed an institutional quality concern. Our goal of reducing erroneous discharge diagnoses with minimal disruption to our existing practice was achieved, positively affecting our patients. Including both nurse leaders and frontline health care workers ensured the success of our project.
Keeping the FAITH!: Psychosocial Factors and Healthy Lifestyle Among African-Americans During the COVID-19 Pandemic
McCoy, Carrie R. , Burgess, Ashya, Johnson, Matthew P. , Jones, Clarence F., Richard, Monisha, Erickson, Jamia, White, Richard O. , Weis, Jennifer A., Abbenyi, Adeline, Jones, Clarence , White, Richard O , Weis, Jennifer, Brockman, Tabetha A , Brewer, LaPrincess C , Sia, Irene G. , Wieland, Mark L. , Brockman, Tabetha A. , Doubeni, Chyke A. , Brewer, LaPrincess C.

Mayo Clinic

Health Promotion Practice | October 22, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15248399251370692 | PMID 41122917 Get It

The COVID-19 pandemic caused unprecedented disruption of social networks and negatively impacted social determinants of health (SDoH, e.g., economic stability, mental health, health care access) among African Americans. The FAITH! (Fostering African-American Improvement in Total Health!) Program, an academic-community partnership with African American churches, pivoted to pandemic-related impacts on health behaviors of African Americans. This exploratory, cross-sectional study examined associations between multilevel factors influencing difficulty maintaining a healthy lifestyle during the early pandemic phase, including mental/emotional health and COVID-19 hardships (e.g., job/food/housing insecurity, paying utilities). An online survey was distributed via FAITH!-affiliated churches and social media. Logistic regression (odds ratios [ORs], adjusted for age/gender) and associated 95% confidence intervals [CIs]) examined associations between difficulty maintaining a healthy lifestyle and multilevel factors. Greater than half of respondents reported difficulty maintaining a healthy lifestyle (N = 169, 54% [91/169]). Adjusted odds of having difficulty maintaining a healthy lifestyle were greater for those reporting mental/emotional health issues (high-stress OR 4.0; 95% CI [1.9,8.9], p < .001); occasional symptoms of depression (OR 3.7; 95% CI [01.9,7.7]; p < .001); anger (OR 2.5; 95% CI [1.2,5.4]; p = .044), and anxiety (OR 2.8; 95% CI [1.4,6.0]; p = .008)). COVID-19 hardships of job insecurity (OR 1.4.; 95% CI [0.7, 2,8]; p = .015), difficulty paying rent (OR 4.4; 95% CI [2.1,9.9]; p < .001) or difficulty paying for food/utilities (OR 5.4; 95% CI [2.6,11.7]; p < .001) were associated with difficulty maintaining a healthy lifestyle. Our study revealed the negative impact of mental/emotional health and COVID-19 hardships on maintaining a healthy lifestyle among African Americans. This could inform SDoH-focused lifestyle interventions during future public health crises.
A Comparative Study of Quality of Life and Oncologic Outcomes in Premenopausal Women with Hormone Receptor-Positive Breast Cancer: Bilateral Oophorectomy vs. Gonadotropin-Releasing Hormone Agonist Therapy
Erdemoğlu, Evrim , Ruddy, Kathryn J. , Buras, Matthew , Quillen, Jaxon , Larson, Nicole L. , Yi, Johnny , Butler, Kristina , Buras, Matthew R , Larson, Nicole , Butler, Kristina A., Ruddy, Kathryn J , Quillen, Jaxon K , Couch, Fergus J. , Olson, Janet E. , Bozzuto, Laura

Mayo Clinic

Cancers | September 5, 2025 | Volume: 17 | Issue: 17 | Pages: 2916

10.3390/cancers17172916 | PMID 40941013 Get It

Background/Objectives: This study aims to evaluate the quality of life (QoL) and oncological outcomes in premenopausal women diagnosed with hormone receptor-positive breast cancer who are receiving either bilateral oophorectomy (BO) or gonadotropin-releasing hormone agonist (GnRH) therapy. Both methods serve to inhibit ovarian function, which is essential for the management of estrogen-dependent tumors; however, their effects on QoL have yet to be fully clarified. Methods: Data were analyzed from the Mayo Clinic Breast Disease Registry, focusing on women under 55 diagnosed with estrogen receptor-positive breast cancer who received either BO or GnRH within one year of diagnosis. QoL was assessed using the Patient-Reported Outcomes Measurement Information System Global-10 (PROMIS-10) at baseline and annually for five years. Results: A total of 181 patients were enrolled in the study; 40 into the BO group and 141 to the GnRH group. Both groups exhibited similar levels of sexual dysfunction after a one-year period; however, the BO group stated a higher frequency of hot flashes. PROMIS-10 scores improved in both mental and physical health over time, with no significant differences between the groups. Within the BO group, one recurrence was observed, in contrast to the GnRH group, which had six events. Nonetheless, the difference in recurrence rates did not reach statistical significance. Conclusions: The long-term QoL and oncologic outcomes for premenopausal women with hormone receptor-positive breast cancer were similar for BO and GnRH therapy. These findings emphasize the need for individualized treatment decisions, considering patient preferences and side effects.
The impact of body size, prior care quality, and weight gain on health care utilization during the COVID‐19 pandemic
Phelan, Sean M. , Barwise, Amelia , Akambase, Jay‐Sharee P., Johnson, Matthew G. , Huang, Lily , Allyse, Megan , Phelan, S M , Allyse, Megan A , Barwise, Amelia K , Philip, Samantha R.

Mayo Clinic

Clinical Obesity | June 12, 2025 | Volume: 15 | Issue: 5 | Pages: No page available

10.1111/cob.70019 | PMID 40484636 Get It

SummaryThe goal of this study was to ascertain the effect of patient body size on clinic‐ or patient‐delayed health care during the COVID‐19 pandemic and factors predicting delay. Primary survey data were collected in August 2021 from 3593 individuals living within the communities near Mayo Clinic facilities in Minnesota, Wisconsin, Arizona, and Florida. More people who identified with the higher‐weight BMI categories reported having their care appointments cancelled (62.3%) compared to those who identified with normative weight (38.0%) or underweight (47.7%; p < .001) and reported more frequently delaying their own care (67.9%) relative to those who identified with normative weight (47.0%) or underweight (62.3%; p < .001). Higher‐weight people were more likely than others to report delay was due to not knowing where to get care (UW: 5.6%, NW: 3.5%, HW: 7.0%, pchi‐square < .001), worrying about weight‐based judgement (UW: 2.1%, NW: 2.1%, HW: 4.5%, pchi‐square < .001), and fearing discrimination (UW: 2.9%, NW: 2.4%, HW: 5.5%, pchi‐square < .001). There was no difference across groups in delay due to fear of COVID‐19 exposure. Weight gain was associated with care delay in higher‐weight and normative weight groups. Having experienced more patient‐centred care pre‐COVID was associated with less care delay in the normative weight group, but more care delay in other groups. Higher‐weight people were more likely to have their care delayed by health care providers and to delay care themselves. Patient weight gain and concerns about discrimination and judgement about weight gain may have driven the delay of needed care during COVID‐19.